publication venue for
- Individualized clinical decisions within standard-of-care pragmatic clinical trials: Implications for consent. 2024
- Taking clinical decisions seriously in standard-of-care pragmatic clinical trials. 2024
- Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance).. 16. 2019
- Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.. 15. 2017
- Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.. 13. 2015
- Ethical complexities in standard of care randomized trials: A case study of morning versus nighttime dosing of blood pressure drugs.. 12. 2015
- Clinical trials in crisis: Four simple methodologic fixes.. 11. 2014
- Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.. 11. 2013
- Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.. 10. 2012
- Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements.. 5. 2008
- Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD).. 3. 2006
- Data and safety monitoring in social behavioral intervention trials: the REACH II experience.. 3. 2006
- Rejoinder.. 15. 2018
- Commentary on Hsiue et al: Cost savings and data limitations of new cancer drug studies. 2020
- Evolving challenges in clinical trials design.. 19. 2022
- Clinical trials in Russia.. 18. 2021
- Editorial: Clinical trial design in the era of COVID-19.. 17. 2020
- The costs of cancer drugs.. 17. 2020
- Editorial.. 16. 2019
- There is still a place for significance testing in clinical trials.. 16. 2019
- Expedited approval programs at the Food and Drug Administration.. 15. 2018
- Zero tolerance for acronyms.. 14. 2017
- Editorial.. 13. 2016
- Editorial.. 13. 2016
- Ethical concerns about adaptive randomization.. 12. 2015
- "Right to Try" laws.. 11. 2014
- Editorial transition.. 11. 2014